NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS




Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Contacts:
John C. Martin, PhD, Chairman and Chief Executive Officer
John F. Milligan, PhD, President and Chief Operating Officer
Norbert W. Bischofberger, PhD, Executive Vice President, Research and Development and Chief Scientific Officer
Kevin Young, Executive Vice President, Commercial Operations
Kristen Metza, Senior Vice President, Human Resources
Susan Hubbard, Vice President, Investor Relations
Amy Flood, Senior Director, Public Affairs


 Key Statistics


Email:
Ownership:
Web Site: Gilead Sciences, Inc.
Employees: 3,200
Symbol: GILD
 



Industry
Biotechnology






 Company News
Gilead Sciences, Inc. (GILD) to Present at the Lazard Capital Markets 6TH Annual Healthcare Conference on Tuesday, November 17 11/12/2009 9:12:13 AM    More...
Concert Pharmaceuticals, Inc. Starts HIV Trial, Bags $12M From GlaxoSmithKline (GSK) to Help Challenge Gilead Sciences, Inc. (GILD)'s (JOBS) Once-Daily Pill 11/9/2009 7:56:18 AM    More...
Graceway Pharmaceuticals, LLC Acquires Worldwide Rights to GS 9191 from Gilead Sciences, Inc. (GILD) (JOBS) 11/6/2009 7:39:56 AM    More...
Gilead Sciences, Inc. (GILD) to Present at the 18th Annual Credit Suisse Healthcare Conference on Wednesday, November 11 11/5/2009 9:54:10 AM    More...
Gilead Sciences, Inc. (GILD) Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in Pulmonary Arterial Hypertension 11/2/2009 9:43:57 AM    More...
Gilead Sciences, Inc. (GILD) to Present at the Oppenheimer 0th Annual Healthcare Conference on Tuesday, November 3 11/2/2009 9:30:28 AM    More...
Gilead Sciences, Inc. (GILD) Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread(R) For Chronic Hepatitis B 11/2/2009 9:24:56 AM    More...
Gilead Sciences, Inc. (GILD)'s (JOBS) Aztreonam for Inhalation Solution to be Reviewed by FDA Anti-Infective Drugs Advisory Committee on December 10, 2009 10/26/2009 6:51:23 AM    More...
Gilead Sciences, Inc. (GILD) Profit Up 36 Pct, HIV Sales Disappoint 10/21/2009 9:56:45 AM    More...
Gilead Sciences, Inc. (GILD) to Release Third Quarter 2009 Financial Results on Tuesday, October 20, 2009 10/14/2009 10:00:52 AM    More...
12345678910...